Letrozole in Assisted Reproductive Technology
Launched by ASSIUT UNIVERSITY · Apr 28, 2015
Trial Information
Current as of May 04, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Unexplained infertility.
- • Tubal factor. Included treated hydrosalpinx and pyosalpinx
- • BMI 18-29.
- • Antral follicle count (AFC) more than 5 follicles in one ovary.
- • Normal male semen analysis.Mild male factor: concentrations 10 million - 20 million sperm/ml. Moderate male factor : concentrations 5 million - 10 million sperm/ml.
- Exclusion Criteria:
- • Patients with Endometriosis.
- • Azoospermic male.
- • BMI more than 29.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials